ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AVO Advanced Oncotherapy Plc

1.925
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Advanced Oncotherapy Plc LSE:AVO London Ordinary Share GB00BD6SX109 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.925 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Medical Laboratories 0 -29.49M -0.0549 -0.35 10.32M
Advanced Oncotherapy Plc is listed in the Medical Laboratories sector of the London Stock Exchange with ticker AVO. The last closing price for Advanced Oncotherapy was 1.93p. Over the last year, Advanced Oncotherapy shares have traded in a share price range of 1.875p to 8.50p.

Advanced Oncotherapy currently has 537,481,209 shares in issue. The market capitalisation of Advanced Oncotherapy is £10.32 million. Advanced Oncotherapy has a price to earnings ratio (PE ratio) of -0.35.

Advanced Oncotherapy Share Discussion Threads

Showing 3976 to 3998 of 5650 messages
Chat Pages: Latest  166  165  164  163  162  161  160  159  158  157  156  155  Older
DateSubjectAuthorDiscuss
19/7/2017
10:59
escapetome,

And prior to this news where were you?

andy
19/7/2017
10:58
So as expected the Bracknor facility hit the rocks and the company is being forced to buy their way out of future commitments. Yes the terms of the new loan are much better, but still leave the company with a significant funding short fall and a repayment date well in advance of operational cash flows.

The crowd seems to have gone wild but as the reality begins to sink in the share price will drop back again.

sweet karolina
19/7/2017
10:57
Can still buy cheaper than the new 25p warrants.
someuwin
19/7/2017
10:56
Got an extra £600 bought 1st thing this morning. I've had a feeling about this for a while.
mrtruth1
19/7/2017
10:54
Shorters getting burnt.
genises
19/7/2017
10:52
Andy....I think so. Its a dawg of course but its a huge vote of confidence! 4 million pounds unsecured because nothing to secure it on.....you don't do that on a whim. I reckon 25-30p is now fair esp if they appoint new management / advisors here. Managed to get 13p myself
barnetpeter
19/7/2017
10:51
Very very poor commentary

Simpletons who could only ever post negatatively day after day.

UP !

escapetohome
19/7/2017
10:51
Positivity. Goes a long way oh, and courage!
mrtruth1
19/7/2017
10:50
mrtruth,

LOL!

Only insiders know what's going to happen, everyone else is assessing the known facts.

andy
19/7/2017
10:50
They must know the true value of this company...
sea and sky
19/7/2017
10:46
Not very good eh ? - those continually posting negative views.

They didnt see the other side of the coin.

escapetohome
19/7/2017
10:45
agreed...its a dawg. But 4 million cash is a lot of money to pour in. I think they are mad myself
barnetpeter
19/7/2017
10:45
This looks like very positive news.
someuwin
19/7/2017
10:45
As I've said over and over again... keep the faith.
mrtruth1
19/7/2017
10:44
barnet,

Are you sure?

Still a long way to go here, although this is clearly good news in the short term.

The £3.9 million loan becomes almost £4.9 million including interest, and there are a whole load of extra warrants out there now, so quite a bit of dilution here.

I guess Bracknor had no choice, their financing deal had come unstuck, and was dragging down the company. At least this gives support in the near term, and should stop the share price decline.

andy
19/7/2017
10:40
Make, this is certainly very good news in principle and practise. But long-termers still neeed an awful lot of luck to get back losses....

Certainly very good for anyone willing to take a chance at this level. But even then not a done deal it will survive.

gerhart
19/7/2017
10:37
bought a few...if only because the shorts are going to close now.
barnetpeter
19/7/2017
10:34
I am afraid there are to many negative posters on this board.

Shares already up 40% on yesterdays close.

Well done all those who have been topping up.

Financing is now secure, technical milestones on track, Harley Street on track. Mr TW most certainly off track.

Good luck all DYOR

makeamillion1
19/7/2017
10:34
And I don't have the funds to buy any... :(

Why didn't Segulah step in earlier? That's the hope I expressed a long time back.

Now who is prepared to short?

gerhart
19/7/2017
10:31
Announcement

19 July 2017

ADVANCED ONCOTHERAPY PLC

(“Advanced Oncotherapy” or the “Company”;)



Financing facility provided by significant shareholders



Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that a consortium formed by AB Segulah and other investors (together “Segulah”;) has made available a £3.9m loan to the Company. The loan will have a two year maturity and a 12% per annum rolled up interest rate. The Segulah group includes AB Segulah, a significant shareholder of the Company, and a group of Swedish investors, including AFMS Radgivning Och Invest AB, Peter Gyllenhammar AB, Mijesi AB and Emendum AB. Segulah will be issued 15.6 million warrants with a strike price of 25p exercisable at any time over the next five years. Part or all of the loan can be redeemed at any time by the Company at 105% of par value. If an equity financing is carried out by the Company at or above 25p before the end of 2017 the loan can be converted into equity at 25p per share.

Agreement with Bracknor

Bracknor has agreed to waive the requirement for the Company to drawdown the minimum of 10 tranches. The Segulah loan, which is equivalent to three tranches, will entitle Bracknor to receive commitment fees on this amount only at a reduced rate of 2.5%. No further fees are owed to Bracknor.



The Company does not intend to use the Bracknor facility in the future. As part of these arrangements the Company will issue 7 million warrants to Bracknor. These warrants are exercisable at 25p and may be exercised at any time over the next five years.





Commenting, Nicolas Serandour, CEO of Advanced Oncotherapy, said: “The Bracknor financing has been valuable to the Company. I would like to thank them for their flexibility in renegotiating its terms. I am particularly pleased to welcome the support shown by our highly valued Swedish investors and in particular the role that Segulah has played in arranging this new facility. Segulah was our first institutional investor and has participated in every financing since that date. The Company has benefitted not only from their financial support but also from advice grounded in their extensive international Med-Tech expertise.”

makeamillion1
18/7/2017
23:40
Thanks Sweet K.AGM is tomorrow I believe.
adealsiddiq110
18/7/2017
23:24
Possibly where I want to buy in, but i believe the AGM is soon?
johnjohntaylor
18/7/2017
19:29
Wrong people running this as has been the case for a long time. Good science/bad business. Evans wasn't the 1st red flag but the video of the demolition block, might be the last before the inevitable. To think they raised at £1.00 not that long ago. At least the BOD are also heavily invested.
waterloo01
Chat Pages: Latest  166  165  164  163  162  161  160  159  158  157  156  155  Older

Your Recent History

Delayed Upgrade Clock